CHOROIDAL THICKNESS IN DIABETIC RETINOPATHY
Authors:
- Inês LaínsILInês Laíns
- João FigueiraJFJoão Figueira
- Ana Rita SantosASAna Rita Santos
- Alda BaltarABAlda Baltar
- Miguel CostaMCMiguel Costa
- Sandrina NunesSNSandrina Nunes
- Cláudia FarinhaCFCláudia Farinha
- Rita PintoRPRita Pinto
- José HenriquesJHJosé Henriques
- Rufino SilvaRSRufino Silva
- 1 June 2014
- journal article
- research article
- Published by Wolters Kluwer Health in Retina
- Vol. 34 (6) , 1199-1207
Abstract
To analyze the effect of anti-vascular endothelial growth factor agents (anti-VEGF) in submacular choroidal thickness (CT) of diabetic retinopathy (DR) patients. Cross-sectional study, which included 25 DR patients (50 eyes) divided in 2 groups, according to DR stage and previous treatments: nonproliferative DR and diffuse diabetic macular edema in both eyes, submitted to macular laser in both eyes and anti-VEGF injection only in 1 eye (nonproliferative diabetic retinopathy + diabetic macular edema group, n = 11); and proliferative DR in both eyes, treated with panretinal photocoagulation in both eyes and anti-VEGF injection only in 1 eye (proliferative diabetic retinopathy group, n = 14). In the study visit, all patients underwent optical coherence tomography with enhanced depth imaging protocol. Choroidal segmentation was performed manually. The medium CT in central macular area (CCT) and the CT in centrofoveal B-scan were obtained automatically. The 25 eyes treated with anti-VEGF showed a reduction on CCT (P = 0.002) and subfoveal CT (P = 0.004), compared with the fellow eyes treated with laser only. Independent evaluation of PDR group revealed similar results (CCT, P = 0.02; subfoveal CT, P = 0.03). In nonproliferative diabetic retinopathy + diabetic macular edema group, CCT was also significantly thinner in eyes treated with anti-VEGF (P = 0.04). A correlation between the number of injections and a thinner CT was found in this group (P = 0.03) and in the evaluation of all eyes together (P = 0.03). Diabetic eyes treated with anti-VEGF agents have reduced CT.Keywords
This publication has 28 references indexed in Scilit:
- Prevalence of diabetic retinopathy in Type 2 diabetes in developing and developed countriesDiabetic Medicine, 2013
- MACULAR AND PERIPAPILLARY CHOROIDAL THICKNESS IN DIABETIC PATIENTSRetina, 2012
- Enhanced Depth Imaging Optical Coherence Tomography in Type 2 DiabetesInvestigative Ophthalmology & Visual Science, 2012
- The relative clinical effectiveness of ranibizumab and bevacizumab in diabetic macular oedema: an indirect comparison in a systematic reviewBMJ, 2012
- CHOROIDAL THICKNESS IN PATIENTS WITH DIABETIC RETINOPATHY ANALYZED BY SPECTRAL-DOMAIN OPTICAL COHERENCE TOMOGRAPHYRetina, 2012
- The worldwide epidemic of diabetic retinopathyIndian Journal Of Ophthalmology, 2012
- Mapping Choroidal and Retinal Thickness Variation in Type 2 Diabetes using Three-Dimensional 1060-nm Optical Coherence TomographyInvestigative Ophthalmology & Visual Science, 2011
- Enhanced Depth Imaging Spectral-Domain Optical Coherence TomographyAmerican Journal of Ophthalmology, 2008
- Choriocapillaris Degeneration and Related Pathologic Changes in Human Diabetic EyesArchives of Ophthalmology (1950), 1998
- Early breakdown of the blood-retinal barrier in diabetes.British Journal of Ophthalmology, 1975